Transaction fees remain the sole earnings driver with fee income above 100% of revenue through 2025 and reaching $1.9B in 2026Q1 before reclassifying to $319.2M in 2026Q3, while the efficiency ratio of 4.3%-29.0% signals substantial operating leverage but structural revenue volatility.
CME Group Inc. (CME) annual income statement — 26-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 |
|---|
| Net Interest Income | 3.11B | -129.7M | -160.9M | -159.4M | -162.7M | -166.9M | -166.2M | -178M | -157.7M | -117M | -123.5M | -117.4M | -119.4M | -151.4M | -132.2M | -116.9M | -140.3M | -131.2M | -69.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NII Growth % | 7776.61% | 19.39% | -0.94% | 2.03% | 2.52% | -0.42% | 6.63% | -12.87% | -34.79% | 5.26% | -5.2% | 1.68% | 21.14% | -14.52% | -13.09% | 16.68% | -6.94% | -87.7% | - | - | - | - | - | - | - | - | - |
| Net Interest Margin % | 1.62% | -0.07% | -0.12% | -0.12% | -0.09% | -0.08% | -0.13% | -0.24% | -0.2% | -0.15% | -0.18% | -0.17% | -0.17% | -0.28% | -0.34% | -0.29% | -0.4% | -0.37% | -0.15% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Interest Income | 3.19B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.8M | 38.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 87.2M | 129.7M | 160.9M | 159.4M | 162.7M | 166.9M | 166.2M | 178M | 157.7M | 117M | 123.5M | 117.4M | 119.4M | 151.4M | 132.2M | 116.9M | 140.3M | 134M | 108.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Loan Loss Provision | 1.01B | 777.3M | 689.4M | 669.2M | 590.4M | 670.1M | 690.3M | 720.7M | 514.5M | 446.9M | 419.7M | 464.1M | 464.7M | 402.8M | 404.6M | 401.1M | 332.4M | 395.3M | 393.2M | 357.3M | 300.06M | 264.38M | 238.06M | 46.58M | 39.86M | 35.07M | 0 |
| Non-Interest Income | 3.78B | 6.52B | 6.13B | 5.58B | 5.02B | 4.69B | 4.88B | 4.87B | 4.31B | 3.64B | 3.6B | 3.33B | 3.11B | 2.94B | 2.91B | 3.28B | 3B | 2.61B | 2.52B | 1.76B | 1.09B | 889.77M | 721.55M | 536.04M | 469.08M | 396.63M | 226.55M |
| Non-Interest Income % | 54.86% | 102.03% | 102.7% | 102.94% | 103.35% | 103.69% | 103.52% | 103.8% | 103.8% | 103.32% | 103.56% | 103.66% | 103.99% | 105.44% | 104.75% | 103.7% | 104.9% | 105.29% | 102.85% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Total Net Revenue | 6.89B | 6.39B | 5.97B | 5.42B | 4.86B | 4.52B | 4.72B | 4.69B | 4.15B | 3.53B | 3.47B | 3.21B | 2.99B | 2.78B | 2.78B | 3.16B | 2.86B | 2.48B | 2.45B | 1.76B | 1.09B | 889.77M | 721.55M | 536.04M | 469.08M | 396.63M | 226.55M |
| Revenue Growth % | 10.57% | 7.06% | 10.14% | 11.59% | 7.38% | -4.13% | 0.58% | 12.97% | 17.69% | 1.61% | 8.17% | 7.23% | 7.48% | 0.09% | -12.05% | 10.49% | 15.52% | 1.06% | 39.67% | 61.12% | 22.5% | 23.31% | 34.61% | 14.28% | 18.27% | 75.07% | - |
| Non-Interest Expense | 1.3B | 1.38B | 1.35B | 1.31B | 1.25B | 1.21B | 1.39B | 1.38B | 1.03B | 745.9M | 824.7M | 756.6M | 760M | 745.1M | 685.8M | 422.9M | 532.5M | 489.1M | 544.48M | 322.25M | 169.03M | 344.25M | 314.69M | 283.33M | 252.85M | 237.72M | 234.63M |
| Efficiency Ratio | 18.9% | 21.66% | 22.59% | 24.26% | 25.75% | 26.7% | 29.46% | 29.46% | 24.8% | 21.14% | 23.75% | 23.57% | 25.39% | 26.76% | 24.65% | 13.37% | 18.6% | 19.73% | 22.2% | 18.35% | 15.51% | 38.69% | 43.61% | 52.86% | 53.9% | 59.93% | 103.57% |
| Operating Income | 4.58B | 4.23B | 3.93B | 3.44B | 3.02B | 2.65B | 2.64B | 2.59B | 2.61B | 2.31B | 2.2B | 1.99B | 1.77B | 1.64B | 1.69B | 2.02B | 1.83B | 1.59B | 1.58B | 1.05B | 620.86M | 477.63M | 355.42M | 206.13M | 176.37M | 123.84M | -8.08M |
| Operating Margin % | 66.49% | 66.18% | 65.86% | 63.4% | 62.1% | 58.49% | 55.91% | 55.18% | 62.81% | 65.5% | 63.38% | 61.96% | 59.08% | 58.78% | 60.81% | 63.88% | 63.95% | 64.11% | 64.51% | 59.82% | 56.96% | 53.68% | 49.26% | 38.45% | 37.6% | 31.22% | -3.57% |
| Operating Income Growth % | - | 7.58% | 14.43% | 13.92% | 14.01% | 0.3% | 1.92% | -0.76% | 12.85% | 5% | 10.65% | 12.46% | 8.03% | -3.25% | -16.28% | 10.38% | 15.23% | 0.44% | 50.62% | 69.2% | 29.99% | 34.38% | 72.43% | 16.87% | 42.42% | 1632.13% | - |
| Pretax Income | 5.77B | 5.33B | 4.54B | 4.15B | 3.49B | 3.37B | 2.72B | 2.69B | 2.78B | 2.53B | 2.29B | 1.96B | 1.77B | 1.6B | 1.69B | 1.94B | 1.72B | 1.44B | 1.25B | 1.1B | 671.66M | 508.38M | 367.66M | 206.13M | 154.23M | 114.36M | -8.08M |
| Pretax Margin % | 83.83% | 83.41% | 76.08% | 76.64% | 71.87% | 74.59% | 57.7% | 57.35% | 66.91% | 71.61% | 65.89% | 60.97% | 59.18% | 57.49% | 60.86% | 61.21% | 60.13% | 57.99% | 50.88% | 62.4% | 61.62% | 57.14% | 50.95% | 38.45% | 32.88% | 28.83% | -3.57% |
| Income Tax | 1.37B | 1.27B | 1.02B | 927.4M | 799.3M | 736.7M | 615.7M | 573.8M | 814.1M | -1.54B | 753.5M | 709.8M | 644.5M | 622.9M | 786.7M | 122.1M | 769.8M | 611.7M | 532.48M | 437.27M | 264.31M | 201.52M | 148.1M | 83.99M | 60.16M | 46.06M | -3.34M |
| Effective Tax Rate % | 23.75% | 23.89% | 22.36% | 22.33% | 22.9% | 21.84% | 22.62% | 21.33% | 29.31% | -60.84% | 32.94% | 36.27% | 36.38% | 38.91% | 46.46% | 6.31% | 44.71% | 42.55% | 42.67% | 39.9% | 39.35% | 39.64% | 40.28% | 40.75% | 39.01% | 40.28% | 41.31% |
| Net Income | 4.4B | 4.04B | 3.53B | 3.23B | 2.69B | 2.64B | 2.11B | 2.12B | 1.96B | 4.06B | 1.53B | 1.25B | 1.13B | 976.8M | 896.3M | 1.81B | 951.4M | 825.8M | 715.49M | 658.53M | 407.35M | 306.86M | 219.56M | 122.13M | 94.07M | 68.3M | -5.91M |
| Net Margin % | 63.92% | 63.28% | 59.07% | 59.53% | 55.41% | 58.29% | 44.63% | 45.13% | 47.26% | 115.19% | 44.19% | 38.85% | 37.66% | 35.07% | 32.21% | 57.28% | 33.23% | 33.31% | 29.17% | 37.5% | 37.37% | 34.49% | 30.43% | 22.78% | 20.05% | 17.22% | -2.61% |
| Net Income Growth % | 17.33% | 14.71% | 9.29% | 19.89% | 2.07% | 25.23% | -0.53% | 7.86% | -51.71% | 164.87% | 23.02% | 10.64% | 15.39% | 8.98% | -50.54% | 90.49% | 15.21% | 15.42% | 8.65% | 61.66% | 32.75% | 39.76% | 79.77% | 29.84% | 37.72% | 1255.9% | - |
| Net Income (Continuing) | 4.4B | 4.06B | 3.53B | 3.23B | 2.69B | 2.64B | 2.11B | 2.12B | 1.96B | 4.06B | 1.53B | 1.25B | 1.13B | 978.1M | 906.7M | 1.81B | 952.1M | 825.8M | 715.49M | 658.53M | 407.35M | 306.86M | 219.56M | 122.13M | 94.07M | 68.3M | -5.91M |
| EPS (Diluted) | 12.27 | 11.16 | 9.67 | 8.86 | 7.40 | 7.29 | 5.87 | 5.91 | 5.71 | 11.94 | 4.53 | 3.69 | 3.35 | 2.92 | 2.70 | 5.43 | 2.86 | 2.48 | 2.43 | 2.99 | 2.32 | 1.76 | 1.28 | 0.72 | 0.63 | 0.47 | -0.04 |
| EPS Growth % | 18.12% | 15.41% | 9.14% | 19.73% | 1.51% | 24.19% | -0.68% | 3.5% | -52.18% | 163.58% | 22.76% | 10.15% | 14.73% | 8.15% | -50.28% | 89.86% | 15.32% | 2.06% | -18.73% | 28.88% | 31.82% | 37.5% | 77.78% | 14.29% | 34.04% | 1243.55% | - |
| EPS (Basic) | - | 11.18 | 9.69 | 8.87 | 7.41 | 7.30 | 5.88 | 5.93 | 5.73 | 12.00 | 4.55 | 3.71 | 3.37 | 2.94 | 2.71 | 5.45 | 2.87 | 2.49 | 2.44 | 3.01 | 2.35 | 1.79 | 1.31 | 0.75 | 0.65 | 0.47 | -0.04 |
| Diluted Shares Outstanding | 358.64M | 360.23M | 359.94M | 359.5M | 359.18M | 358.93M | 358.52M | 358.24M | 343.74M | 340.23M | 338.97M | 337.89M | 336.06M | 334.4M | 332.32M | 333.81M | 332.48M | 332.74M | 294.83M | 220.53M | 175.62M | 174.19M | 172.05M | 169.67M | 150.3M | 146.37M | 143.87M |
Quick answers to the most common questions about buying CME stock.
For fiscal year 2025, CME Group Inc. (CME) reported total revenue of $6.39B. This represents a 2720.9% increase compared to $226.6M in 2000.
CME Group Inc. (CME) is profitable, generating $4.04B in net income for the fiscal year ending 2025 with a net profit margin of 63.3%.
CME Group Inc. (CME) reported an operating income of $4.23B, resulting in an operating profit margin of 66.2%. This margin reflects the operational efficiency of the business before interest and taxes.
CME Group Inc. (CME) generated $5.61B in gross profit for the year, representing a gross profit margin of 87.8%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Revenue classification volatility
Metrics are mathematically derived from official filings.
Transaction Fees Remain Sole Earnings Engine
According to CME's reported figures, non-interest income has consistently represented over 100% of total revenue through 2024-2025, with fee income reaching $1.9B in 2026Q1 before a sharp reclassification to $319M in Q3, highlighting the fragility of apparent revenue diversification.
The fee-income dominance is the defining characteristic of CME's income statement: clearing and transaction fees constitute the entire revenue base, with the 'Fee %' metric exceeding 102% in every quarter from 2024Q2 through 2026Q1. This means interest income is not merely supplemental — it is structurally negative, reflecting interest expense on cleared deposits exceeding interest earned on collateral. The $1.9B peak in 2026Q1 fee income, followed by the collapse to $319.2M in Q3, suggests that some portion of what was previously classified as fee revenue may have been reclassified as NII. Investors should monitor whether the underlying clearing and transaction fee trajectory, independent of classification, continues to benefit from the record H1 2026 volumes referenced in recent filings.
Negative NII Pattern Disrupted Abruptly
Based on CME's quarterly disclosures, net interest income had been consistently negative in the range of -$40M to -$44M for eight consecutive quarters through 2025Q3, then surged to $1.7B in 2025Q4 and $1.4B in 2026Q3, representing a structural discontinuity that warrants careful interpretation.
The persistent negative NII through 2024-2025 reflects the economics of a clearinghouse: interest expense on performance bonds and cleared member deposits exceeded interest income earned on invested collateral, creating a modest drag on total revenue. The sudden $1.7B NII spike in 2025Q4 and the $1.4B figure in 2026Q3 appear inconsistent with a clearinghouse's traditional interest income profile and may reflect either a reclassification of previously fee-based revenue into NII, a change in collateral investment policy, or shifts in how cleared deposits are accounted for. The concurrent collapse of fee income to $319.2M in 2026Q3 (from $1.7B in Q2) strongly suggests that the boundary between NII and fee income has shifted rather than an entirely new revenue stream emerging. Analysts should seek management's explanation for this reclassification to understand whether the underlying economics of the clearing franchise have changed.
2026 Marks Structural Revenue Reorganization
CME's 2026 quarters display the most dramatic income statement restructuring in the ten-quarter dataset, with 2026Q2 combining record $1.7B fee revenue against a $568.3M provision spike and 2.5% EPS growth, while Q3 delivered $2.89 EPS on an entirely different revenue composition with NII at $1.4B.
The contrast between 2026Q2 and 2026Q3 encapsulates the key inflection: Q2 showed record fee-based revenue with an unusually elevated provision of $568.3M — more than double the $177.6M average in prior quarters — yet only managed 2.5% EPS growth, implying that cost or credit factors offset volume gains. Q3 then presented a dramatically different picture with near-zero fee income ($319.2M), $1.4B in NII, a normalized $60.7M provision, and 16.1% EPS growth. This pattern suggests either a mid-year accounting policy change, a reclassification of collateral-related revenue, or a one-time event in Q2 that compressed profitability. The fact that 2026Q1 produced the highest quarterly EPS ($3.18) in the entire dataset at $1.9B revenue indicates that CME's absolute earnings power remains strong, but the composition has become significantly less transparent to investors.
Efficiency Ratio Gaps All Exchange Peers
CME's efficiency ratio has ranged from 4.3% to 29.0% over the last ten quarters, representing a substantial structural advantage over peers like ICE at 38.7% and CBOE at 32.1%, as reported in comparative financial data reflecting the company's near-zero marginal cost of matching additional trades.
Even at its weakest point (29.0% in 2026Q3), CME's efficiency ratio remains materially superior to every listed exchange peer, consistent with a business model where the incremental cost of clearing an additional contract is negligible relative to the transaction fee collected. The 4.3% ratio in 2026Q2, combined with $1.1B operating income on $1.7B revenue, reflects both exceptional operating leverage and the unusually favorable mix of high-volume, high-RPC interest rate products during the volatile rate environment. However, the NIM figures — ranging from -0.0% to 0.9% — confirm that CME is not earning meaningful net interest margin in any traditional banking sense; these figures likely reflect only incidental interest flows on cleared collateral, not a managed asset-liability position. The extreme efficiency profile appears sustainable while volumes remain elevated, but the reclassification of revenue lines in 2026 makes trend comparison of underlying cost management increasingly difficult.
Provision Spike Signals Clearing Risk Awareness
CME's provision for credit losses surged to $568.3M in 2026Q2, more than three times the $165-180M quarterly range maintained through 2024 and 2025, before normalizing to $60.7M in Q3, a pattern that may indicate a one-time clearing member default event or a recalibration of default fund assessments.
For a clearinghouse, provisions represent the risk of clearing member defaults on performance bonds — a fundamentally different exposure from traditional loan loss provisions. The $568.3M charge in 2026Q2 stands out sharply against the remarkably stable $164.6-$197.4M range across the other nine quarters, suggesting either an isolated event or a forward-looking increase in default risk reserves. The rapid normalization to $60.7M in 2026Q3, the lowest provision in the dataset, implies the Q2 charge was likely non-recurring rather than indicative of a deteriorating credit environment. However, the coincidence of record volumes and an elevated provision in the same quarter warrants attention: if the spike reflected a clearing member under stress during peak volatility, investors should monitor whether CME's default fund remains adequately capitalized to absorb future stress scenarios.
Earnings Quality Masked by Classification Shifts
Despite reporting record H1 2026 volumes, CME's EPS declined from $3.24 in 2025Q4 to $2.88 in 2026Q2 — a 11% sequential drop — while the revenue composition shifted so dramatically that traditional trend analysis becomes unreliable, raising questions about underlying earnings durability.
The most significant challenge to CME's earnings quality is the apparent instability of its revenue classification: NII swung from -$43.6M in Q1 to +$43.6M in Q2 to +$1.4B in Q3 2026, while fee income moved inversely. This level of classification volatility makes it difficult to assess whether the company is genuinely growing its core clearing franchise or whether accounting changes are reshuffling the same revenue pool. The 2026Q2 EPS of $2.88, achieved despite what management characterized as record volumes, represents a sequential decline from Q1's $3.18 and may indicate that the cost base or credit provisions grew faster than revenue. Additionally, the persistent competitive overhang from FMX Futures Exchange (backed by BGC Group) targeting CME's U.S. Treasury futures franchise — its highest-margin product line — could structurally compress rate per contract if liquidity migrates. Combined with the Basel III Endgame's potential to reduce clearing member trading capacity, the market's premium valuation may be underweighting these structural risks to CME's fee-generation model.